L Roman

875 total citations · 1 hit paper
9 papers, 676 citations indexed

About

L Roman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, L Roman has authored 9 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in L Roman's work include Cancer Treatment and Pharmacology (5 papers), Prostate Cancer Treatment and Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). L Roman is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Prostate Cancer Treatment and Research (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). L Roman collaborates with scholars based in Russia, United States and Taiwan. L Roman's co-authors include Laila I. Muderspach, Franco M. Muggia, Susan Jeffers, Alexander Burnett, Agustin Garcia, John D. Hainsworth, Matthew Tan, Beatrice Uziely, C. Paul Morrow and Linda J. Paradiso and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Gynecologic Oncology.

In The Last Decade

L Roman

9 papers receiving 650 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

1997 513 citations Franco M. Muggia, John D. Hainsworth et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L Roman Russia	6	288	277	219	138	123	9	676
Agustin Garcia United States	4	263 0.9×	258 0.9×	198 0.9×	171 1.2×	170 1.4×	7	715
Linda J. Paradiso United States	9	245 0.9×	250 0.9×	204 0.9×	129 0.9×	194 1.6×	20	701
Matthew Tan United States	7	558 1.9×	262 0.9×	335 1.5×	126 0.9×	208 1.7×	10	1.1k
Vito Carone Italy	9	135 0.5×	313 1.1×	206 0.9×	87 0.6×	68 0.6×	12	600
George Lewandowski United States	13	304 1.1×	441 1.6×	205 0.9×	31 0.2×	159 1.3×	26	801
N Onetto United States	14	651 2.3×	141 0.5×	120 0.5×	54 0.4×	130 1.1×	21	948
A. B. Lopez Denmark	7	250 0.9×	258 0.9×	187 0.9×	40 0.3×	50 0.4×	9	517
Elżbieta Nowara Poland	18	526 1.8×	124 0.4×	72 0.3×	84 0.6×	359 2.9×	70	1.0k
Elizabeth B. Somers United States	17	390 1.4×	228 0.8×	96 0.4×	97 0.7×	357 2.9×	28	1.1k
Florette K. Hazard United States	13	107 0.4×	151 0.5×	129 0.6×	104 0.8×	182 1.5×	44	747

Countries citing papers authored by L Roman

Since Specialization

Citations

This map shows the geographic impact of L Roman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Roman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Roman more than expected).

Fields of papers citing papers by L Roman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Roman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Roman. The network helps show where L Roman may publish in the future.

Co-authorship network of co-authors of L Roman

This figure shows the co-authorship network connecting the top 25 collaborators of L Roman. A scholar is included among the top collaborators of L Roman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Roman. L Roman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Gianni, Luca, Giampaolo Bianchini, Astrid Kiermaier, et al.. (2011). S5-1: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker Analyses of a 4-Arm Randomized Phase II Study (NeoSphere) in Patients (pts) with HER2−Positive Breast Cancer (BC).. Cancer Research. 71(24_Supplement). S5–1. 33 indexed citations

2.

Gianni, Luca, Tadeusz Pieńkowski, Y-H Im, et al.. (2010). Abstract S3-2: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Antitumor and Safety Analysis of a Randomized Phase II Study ('NeoSphere'). Cancer Research. 70(24_Supplement). S3–2. 48 indexed citations

3.

Jager, Robert L. De, et al.. (2009). Results of a phase II study of picoplatin with docetaxel and prednisone in first-line treatment of castration-resistant prostate cancer (CRPC). Journal of Clinical Oncology. 27(15_suppl). 5140–5140. 3 indexed citations

4.

Capizzi, Robert L., L Roman, S. Tjulandin, et al.. (2008). Phase II trial of C1311, a novel inhibitor of topoisomerase II in advanced breast cancer. Journal of Clinical Oncology. 26(15_suppl). 1055–1055. 25 indexed citations

5.

Breitz, Hazel B., L Roman, Petr Karlov, et al.. (2008). A phase II study of picoplatin with docetaxel and prednisone in chemotherapy-naïve patients with metastatic hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 26(15_suppl). 5153–5153. 2 indexed citations

6.

Бердов, Б. А., L Roman, Alexander Luft, et al.. (2008). Intraoperative, adjuvant treatment of gastric cancer with the trifunctional antibody catumaxomab compared to surgery alone: A phase II study. Journal of Clinical Oncology. 26(15_suppl). 15529–15529. 8 indexed citations

7.

Roman, L, Petr Karlov, А. Д. Каприн, Oleg Gladkov, & Hazel B. Breitz. (2007). Phase I study of picoplatin and docetaxel (D) with prednisone (P) in patients (pts) with chemotherapy-naive metastatic hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 25(18_suppl). 15546–15546. 1 indexed citations

8.

Roman, L, et al.. (2000). Phase II Study of Liposomal Doxorubicin in Advanced Gynecologic Cancers. Gynecologic Oncology. 78(2). 143–147. 43 indexed citations

9.

Muggia, Franco M., John D. Hainsworth, Susan Jeffers, et al.. (1997). Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.. Journal of Clinical Oncology. 15(3). 987–993. 513 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact